Evidence mapPaperPMID 35673511Full record

ReviewJournal of diabetes and metabolic disorders2022

Anti-diabetic potential of Urtica Dioica: current knowledge and future direction.

Anita Chehri, Reza Yarani, Zahra Yousefi, Tannaz Novin Bahador, Seyed Kazem Shakouri, Alireza Ostadrahimi, Majid Mobasseri, Flemming Pociot, Mostafa Araj-Khodaei

Abstract readReview
In one paragraph

Review in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2024
    Review
  4. Nettle (Aquaculture nutrition · 2023
    Review
  5. Synthesis of Green Engineered Silver Nanoparticles throughAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Ethnopharmacological Effects ofAntioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anita ChehriStudent Research Committee, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza YaraniType 1 Diabetes Research, Department of Clinical Research, Translational , Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Zahra YousefiPsychiatry Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Tannaz Novin BahadorPhysical Medicine Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Seyed Kazem ShakouriPhysical Medicine Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Alireza OstadrahimiDepartment of Clinical Nutrition, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Majid MobasseriDepartment of Internal Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Flemming PociotType 1 Diabetes Research, Department of Clinical Research, Translational , Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Mostafa Araj-KhodaeiDepartment of Persian Medicine, Faculty of Traditional Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This review summarizes studies on the anti-diabetic effect of Urtica Dioica (UD) in Type-2-diabetes. Materials and methods: We studied worldwide traditional medicines, old texts, and published literature for anti-diabetic effect of UD. Electronic databases comprising PubMed, Web of Science, Science Direct, Scopus and Google Scholar were searched to collect articles published between 1990 and 2021 years. Results: Our literature investigation suggests UD as a glucose lowering, blood lipid regulating, anti-inflammatory and anti-oxidation plant. Conclusions: UD's anti-diabetic properties make it potential traditional therapeutics for lowering the clinical manifestations of T2DM through affecting hyperglycemia and therefore suggest it as a proper medication with no or limited side effects.

Indexed as

Diabetes mellitusInsulinTraditional medicineUrtica dioica

Identifiers

PMID35673511
PMCPMC9167344

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.